1-(4-(Benzyloxy)-3,5-dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol, 97%, 100mg

4-(3-FLUORO-4-NITROPHENYL)MORPHOLINE, 97.0%, 5g

1-(Pyrazine-2-carbonyl)azetidine-3-carboxylic acid, 98%, 1g

4-(1-(tert-Butoxycarbonyl)piperidin-4-yl)phenylboronic acid, 97%, 250mg

Sodium 2-Naphthalenesulfonate>98.0%(HPLC)(T)25g

2-Chloro-6-fluoro-3-methoxybenzoic acid, 97.0%, 10g

(2S,4S)-tert-Butyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate, 98%, 1g

Ethanol, min. 80%, 2.5 l, plastic packaging.

(11bR)-4-Hydroxy-2,6-bis(2,4,6-trimethylphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 97%, 1g

(R)-ETHYL OXIRANE-2-CARBOXYLATE, 95%, 250mg

2-HYDROXY-2-(4-METHYLPHENYL)ETHYLAMINE OXALATE, 95.0%, 1g

GC capillary column ROTI®Cap-FFAP, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Ethyl 5-amino-6-bromo-2-methylnicotinate, 95+%, 100mg